Cardiac Signal Vector Discrimination for Arrhythmia Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable cardiac rhythm management systems face challenges in accurately discriminating between different types of arrhythmias, such as supra-ventricular tachycardia and ventricular tachycardia, due to the complexity of cardiac signal analysis and the need for precise monitoring and tracking of cardiac activation sequences.
Innovation Solution
The implementation of cardiac signal separation techniques using multiple implantable electrodes to produce cardiac signal vectors associated with cardiac activation sequences, allowing for the detection of changes and discrimination between various arrhythmias by analyzing phase, magnitude, and variance changes in these vectors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional single-lead ECG sensing is used, then device simplicity is maintained, but arrhythmia discrimination accuracy deteriorates
Solution Approach 1:
The patent segments the cardiac signal analysis by separating atrial and ventricular activation sequences through independent vector analysis. Multiple ECG leads are processed to generate separate activation maps for atria and ventricles, allowing precise discrimination of arrhythmia origins without requiring overly complex integrated analysis
Solution Approach 2:
The patent transitions from traditional scalar ECG amplitude analysis to vector-based spatial analysis. By representing cardiac activation as vectors with magnitude and direction in multiple dimensions, the system achieves superior arrhythmia discrimination capability, distinguishing between similar arrhythmia types that appear identical in conventional ECG waveforms
2Reliability
If multiple ECG leads are utilized, then arrhythmia detection capability is improved, but device complexity increases
Solution Approach 1:
The patent divides the multi-lead ECG processing into separate atrial and ventricular analysis streams. Each stream independently processes relevant leads to generate activation sequences, reducing the computational burden compared to analyzing all leads simultaneously and improving reliability through specialized processing for each chamber
Solution Approach 2:
The patent transforms raw multi-lead ECG signals into derived parameters including activation timing, vector magnitude, and spatial orientation. By changing from direct waveform analysis to parameter-based analysis, the system achieves more reliable arrhythmia detection while managing device complexity through standardized parameter extraction algorithms
3Measurement precision
If detailed cardiac activation sequence monitoring is implemented, then diagnostic accuracy is improved, but processing time increases
Solution Approach 1:
The patent performs preliminary processing by continuously monitoring and pre-processing ECG signals to establish baseline activation patterns. When arrhythmia detection is required, the pre-processed data and established algorithms enable rapid analysis, reducing the time penalty associated with detailed activation sequence monitoring
Solution Approach 2:
The patent implements selective detailed analysis by skipping full activation sequence processing for normal rhythms and reserving detailed monitoring for suspicious or arrhythmic events. This approach maintains high diagnostic accuracy when needed while minimizing processing time during normal cardiac function
Data Source
AI summary
Cardiac monitoring and/or stimulation methods and systems provide for monitoring, diagnosing, defibrillation and pacing therapies, or a combination of these capabilities, including cardiac systems incorporating or cooperating with neuro-stimulating devices, drug pumps, or other therapies. Embodiments relate generally to implantable medical devices employing automated cardiac activation sequence monitoring and/or tracking for arrhythmia discrimination. Embodiments are directed to devices and methods involving sensing a plurality of composite cardiac signals using a plurality of implantable electrodes. A source separation is performed using the sensed plurality of composite cardiac signals and the separation produces one or more cardiac signal vectors associated with one or more cardiac activation sequences that is indicative of ischemia. A change of the one or more cardiac signal vectors is detected using the one or more cardiac signal vectors. Cardiac arrhythmias are discriminated using the one or more cardiac signal vectors.